Cargando…
Analysis of small-sample clinical genomics studies using multi-parameter shrinkage: application to high-throughput RNA interference screening
High-throughput (HT) RNA interference (RNAi) screens are increasingly used for reverse genetics and drug discovery. These experiments are laborious and costly, hence sample sizes are often very small. Powerful statistical techniques to detect siRNAs that potentially enhance treatment are currently l...
Autores principales: | van de Wiel, Mark A, de Menezes, Renée X, Siebring-van Olst, Ellen, van Beusechem, Victor W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654870/ https://www.ncbi.nlm.nih.gov/pubmed/23819807 http://dx.doi.org/10.1186/1755-8794-6-S2-S1 |
Ejemplares similares
-
A genome‐wide siRNA screen for regulators of tumor suppressor p53 activity in human non‐small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment
por: Siebring‐van Olst, Ellen, et al.
Publicado: (2017) -
A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting
por: Hodzic, Jasmina, et al.
Publicado: (2015) -
Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens
por: Brachtlova, Tereza, et al.
Publicado: (2018) -
Host gene targets for novel influenza therapies elucidated by high‐throughput RNA interference screens
por: Meliopoulos, Victoria A., et al.
Publicado: (2012) -
Drug sensitivity prediction with normal inverse Gaussian shrinkage informed by external data
por: Münch, Magnus M., et al.
Publicado: (2020)